The working group will make recommendations about the future use of puberty suppressants and cross-sex hormones as part of the next stage of a review of gender identity development services for children and young people.
NHS England introduced a new service specification in 2016 but said it was committed to carrying out a review of gender identity development services and associated policies for 2020.
These nationally commissioned services support young people and their families, providing counselling and psychological support.
In some cases, young people are prescribed puberty suppressants and from around 16, cross-sex hormones.
The independent group, chaired by former president of the Royal College of Paediatrics and Child Health Dr Hilary Cass, will be made up of 20 members from a range of clinical and academic backgrounds. It will also include members of the public.
Register Now to Continue Reading
Thank you for visiting Children & Young People Now and making use of our archive of more than 60,000 expert features, topics hubs, case studies and policy updates. Why not register today and enjoy the following great benefits:
What's Included
-
Free access to 4 subscriber-only articles per month
-
Email newsletter providing advice and guidance across the sector
Already have an account? Sign in here
